The term "Bull Pharma" has arisen recently, fueling a heated debate surrounding some pharmaceutical corporations . Allegations of misleading marketing strategies , excessive drug rates, and a potential disregard for patient well-being have led to increasing scrutiny from regulators , patient advocac